Analystreport

LogicBio Therapeutics, Inc. (NASDAQ: LOGC) was downgraded by analysts at William Blair to a "market perform" rating.

LogicBio Therapeutics, Inc.  (LOGC) 
Last logicbio therapeutics, inc. earnings: 8/13 08:00 am Check Earnings Report